Respicardia Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$98.4M
Industry:Medical Equip
Lead Investor(s):ZOLL Medical Corporation

Estimated Revenue & Financials

  • Respicardia's estimated annual revenue is currently $18.1M per year.(?)
  • Respicardia received $58.5M in venture funding in December 2017.
  • Respicardia's estimated revenue per employee is $251,000
  • Respicardia's total funding is $98.4M.

Employee Data

  • Respicardia has 72 Employees.(?)
  • Respicardia grew their employee count by 41% last year.
  • Respicardia currently has 1 job openings.

Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remed® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular healthone breath at a time.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals